Omnicell Reports Executive Changes and Compensation Arrangements

TL;DR

**Omnicell just filed an 8-K about executive changes and compensation, so keep an eye out for potential strategic shifts!**

AI Summary

Omnicell, Inc. filed an 8-K on February 29, 2024, reporting an event on February 23, 2024, concerning the departure or election of directors or officers and compensatory arrangements. The filing indicates a change in leadership or executive compensation, which is a standard disclosure for public companies. The company's business address is 4220 North Freeway, Fort Worth, TX 76137.

Why It Matters

Changes in executive leadership or compensation can signal strategic shifts or financial health, impacting investor confidence and future company direction.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure about executive changes and compensation, not indicating immediate financial distress or major operational risks.

Key Players & Entities

• OMNICELL, INC. (company) — Registrant
• February 23, 2024 (date) — Date of earliest event reported
• February 29, 2024 (date) — Filing date
• Fort Worth, TX (location) — Company headquarters
• Delaware (location) — State of incorporation

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock, $0.001 par value OMCL NASDAQ Global Select M

Filing Documents

• tm247482d1_8k.htm (8-K) — 25KB
• 0001104659-24-029356.txt ( ) — 193KB
• omcl-20240223.xsd (EX-101.SCH) — 3KB
• omcl-20240223_lab.xml (EX-101.LAB) — 33KB
• omcl-20240223_pre.xml (EX-101.PRE) — 22KB
• tm247482d1_8k_htm.xml (XML) — 3KB

02 Departure of Directors or Certain Officers; Election of

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 23, 2024, Joseph B. Spears notified Omnicell, Inc. (the "Company" or "Omnicell") that he will retire and depart from the Company, effective May 31 , 2024 (the "Spears Retirement Date"). Mr. Spears' departure is not due to any disagreement with the Company on any matter relating to the Company's operations, policies or practices (financial reporting, accounting or otherwise). The Company would like to thank Mr. Spears for his contributions to the Company throughout his employment, and for playing an important role in the Company's evolution. In addition, effective March 18, 2024, Omnicell has hired Brian Nutt, age 54, to serve as Vice President, Chief Accounting Officer, of the Company. Upon Mr. Nutt joining the Company, Mr. Nutt will also be designated Corporate Controller and principal accounting officer of the Company for purposes of the Company's filings with the U.S. Securities and Exchange Commission. Accordingly, upon Mr. Nutt joining the Company, Mr. Spears will step down from his positions as Senior Vice President, Chief Accounting Officer of the Company. Mr. Spears will also cease serving as the Company's Corporate Controller and principal accounting officer upon Mr. Nutt's appointment. Following Mr. Spears stepping down from his positions, he will remain with the Company in an executive adviser capacity to assist with the transition of his roles and responsibilities until the Spears Retirement Date. Prior to joining Omnicell, since February 2015, Mr. Nutt served as Vice President and Controller, Labcorp Drug Development Segment of Laboratory Corporation of America Holdings, a leading global life sciences company. From May 2011 to February 2015, Mr. Nutt served as Chief Accounting Officer of Covance Inc. ("Covance"), a leading drug development services company. Prior thereto he held s

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. OMNICELL, INC. Date: February 29, 2024 /s/ Nchacha E. Etta Nchacha E. Etta Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR